SCHEMBL20732809

SCHEMBL20732809

COc1ccc(-c2cnc3[nH]cc(C(=O)c4ccncc4)c3c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AXL P30530 4/20 0.66
AAK1 Q2M2I8 4/20 0.62
KIT P10721 2/20 0.52
PIK3CA P42336 1/20 0.51
NTRK1 P04629 2/20 0.50
CCNT1 O60563 1/20 0.50
CCNA2 P20248 1/20 0.50
CDK2 P24941 1/20 0.50
CDK9 P50750 1/20 0.50
NEK1 Q96PY6 1/20 0.50
DYRK1A Q13627 1/20 0.49
SLC2A1 P11166 1/20 0.48
BRD4 O60885 1/20 0.48
SGK1 O00141 1/20 0.47
CAMKK2 Q96RR4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20732953 0.85 AAK1 (0.53) AXLAAK1KITPIK3CANTRK1
SCHEMBL20733101 0.84 AXL (0.60) AXLAAK1KITPIK3CANTRK1
SCHEMBL20732813 0.83 AXL (0.51) AXLAAK1KITNTRK1NEK1
SCHEMBL20733095 0.83 AAK1 (0.66) AXLAAK1KITPIK3CANTRK1
SCHEMBL857686 0.81 AAK1 (0.56) AXLAAK1NTRK1NEK1DYRK1A
SCHEMBL415002 0.81 AXL (0.69) AXLAAK1KITNTRK1NEK1
SCHEMBL412853 0.80 NEK1 (0.58) AXLAAK1KITNTRK1NEK1
SCHEMBL411355 0.79 NPSR1 (0.53) AXLAAK1NTRK1DYRK1ABRD4
SCHEMBL858329 0.79 AAK1 (0.67) AXLAAK1KITNTRK1CDK2
SCHEMBL20732957 0.79 AAK1 (0.53) AXLAAK1NTRK1NEK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 EP claimed
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 WO disclosed